CDC23

Cell division cycle protein 23 homolog · Q9UJX2 · CDC23 on Sugi Atlas →

0 patent compounds predicted against CDC23, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CDC23 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors for Treatment of Breast Cancer in Egypt PHASE4COMPLETED
Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases PHASE3COMPLETED
A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia PHASE3COMPLETED
Everolimus in CDK12-Deficient Metastatic Colorectal Cancer (EVER-RECODE) PHASE1/PHASE2NOT_YET_RECRUITING
Abemaciclib With or Without Atezolizumab for mCRPC PHASE2COMPLETED
TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer PHASE2UNKNOWN
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer PHASE2COMPLETED
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6 PHASE2RECRUITING
INCB018424 in Patients With Advanced Hematologic Malignancies PHASE2COMPLETED
A Study of BN104 in the Treatment of Acute Leukemia PHASE1/PHASE2ACTIVE_NOT_RECRUITING
I/II Phase Study Evaluating M1774 in Combination With Fulvestrant in HR+ and HER2- Advanced Breast Cancers PHASE1/PHASE2NOT_YET_RECRUITING
AZD1775 for Advanced Solid Tumors PHASE1COMPLETED
Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas PHASE1COMPLETED
Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid Leukemia PHASE1WITHDRAWN
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors PHASE1COMPLETED
A Clinical Study of TQB3824 in Subjects With Advanced Cancer PHASE1UNKNOWN
Safety Study of Infusion of SGT-53 to Treat Solid Tumors PHASE1COMPLETED
Study of ABT-751 in Patients With Refractory Hematologic Malignancies PHASE1COMPLETED
Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer PHASE1COMPLETED
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Study of the Effect of Innate on the Inflammatory Response to Endotoxin nanRECRUITING
Unusual Infiltrative Patterns of Malignant Cells in Endometrial Carcinoma and Immunohistochemical Expression of P53 nanUNKNOWN
PCM1-JAK2 in Therapy Related Neoplasms nanUNKNOWN
PCD New Gene Discovery nanCOMPLETED
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy nanCOMPLETED
Susceptibility to Infections in Ataxia Telangiectasia nanCOMPLETED
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Genetic Analysis of Familial Melanoma nanCOMPLETED
Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders nanWITHDRAWN

Related proteins — ESM-2 sequence neighbours (a CDC23 binder may also engage these)

ProteinNameSimilarity
Q8BGZ4 1.000 Q8BGZ4 →
A1A4R8 1.000 A1A4R8 →
Q5R882 0.991 Q5R882 →
Q6TGY8 0.989 Q6TGY8 →
Q5E993 0.988 Q5E993 →
Q9CRD2 0.988 Q9CRD2 →
B0BNG0 0.987 B0BNG0 →
B3DNN5 0.984 B3DNN5 →
EMC2 ER membrane protein complex subunit 2 0.982 landscape →
GTF3C3 General transcription factor 3C polypeptide 3 0.981 landscape →
Q5M7J9 0.979 Q5M7J9 →
SKIC3 Superkiller complex protein 3 0.977 landscape →
Q8AVU9 0.977 Q8AVU9 →
Q8VY89 0.977 Q8VY89 →
F8VPK0 0.976 F8VPK0 →
ANAPC7 Anaphase-promoting complex subunit 7 0.975 landscape →
Q9V345 0.975 Q9V345 →
Q9DBB4 0.974 Q9DBB4 →
Q6INS3 0.974 Q6INS3 →
Q8VZM1 0.974 Q8VZM1 →
Q9WVM3 0.974 Q9WVM3 →
Q9STS3 0.974 Q9STS3 →
Q5F3K0 0.973 Q5F3K0 →
CTR9 RNA polymerase-associated protein CTR9 homolog 0.973 landscape →
Q6N069 0.972 Q6N069 →
Q12996 0.971 Q12996 →
Q6P3X3 0.971 Q6P3X3 →
Q8TAM2 0.971 Q8TAM2 →
Q28G25 0.971 Q28G25 →
Q99LI7 0.971 Q99LI7 →